Please assess the completion status of the following clinical trial:

Trial Title: Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stable angina~* Low-density lipoprotein (LDL) cholesterol 70-160 mg/dl~Exclusion Criteria:~* Renal failure~* Age\>80~* Simvastatin current treatment\>20mg~* Hepatic disease~* Inflammatory diseases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Simvastatin 80 mg (Type: ACTIVE_COMPARATOR): Patients were treated with simvastatin 80 mg for 6 weeks
- Ezetimibe 10 mg / Simvastatin 20 mg (Type: ACTIVE_COMPARATOR): Patients were treated with daily Ezetimibe 10 mg / Simvastatin 20 mg for 6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).